ArticleClinical and experimental immunology2021

16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.

Manuel Othoniel López-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.